Switching biologics in children with psoriasis: Results from the BiPe cohort.

Céline PhanAlain BeauchetZiad ReguiaiMaëlla Severino-FreireJuliette Mazereeuw-HautierAnne-Claire BursztejnSébastien BarbarotSmaïl Hadj-RabiaCéline GirardAlice PhanJean-Philippe LacourAudrey LasekClaire AbasqEmilie BrenautMarc PerrusselCatherine DroitcourtStéphanie MalletMaryam PiramAnne-Claire FougerousseHugues BarthélémyXavier BalguérieEmmanuel Mahénull null

Published in: Pediatric dermatology (2021)

Our study provided key insights into the real-life clinical practice of switching biologics in pediatric psoriasis patients. However, more information and guidance on switching biologics in pediatric psoriasis are needed to improve real-life practice and outcomes.

Keyphrases

end stage renal disease
clinical practice
ejection fraction
chronic kidney disease
newly diagnosed
healthcare
primary care
young adults
atopic dermatitis
prognostic factors
type diabetes
adipose tissue
insulin resistance